| 1 |
Daly SR, Bellott BJ, McAlister DR, Horwitz EP, Girolami GS. Pr(H3BNMe2BH3)3 and Pr(thd)3 as Volatile Carriers for Actinium-225. Deposition of Actinium-Doped Praseodymium Boride Thin Films for Potential Use in Brachytherapy. Inorg Chem 2022. [PMID: 35510902 DOI: 10.1021/acs.inorgchem.2c00442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Karpov TE, Muslimov AR, Antuganov DO, Postovalova AS, Pavlov DA, Usov YV, Shatik SV, Zyuzin MV, Timin AS. Impact of metallic coating on the retention of 225Ac and its daugthers within core-shell nanocarriers. J Colloid Interface Sci 2022;608:2571-83. [PMID: 34801240 DOI: 10.1016/j.jcis.2021.10.187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Kleynhans J, Sathekge M, Ebenhan T. Obstacles and Recommendations for Clinical Translation of Nanoparticle System-Based Targeted Alpha-Particle Therapy. Materials (Basel) 2021;14:4784. [PMID: 34500873 DOI: 10.3390/ma14174784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 4 |
Trujillo-Nolasco M, Morales-Avila E, Cruz-Nova P, Katti KV, Ocampo-García B. Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications. Pharmaceutics 2021;13:1123. [PMID: 34452084 DOI: 10.3390/pharmaceutics13081123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 5 |
Muslimov AR, Antuganov D, Tarakanchikova YV, Karpov TE, Zhukov MV, Zyuzin MV, Timin AS. An investigation of calcium carbonate core-shell particles for incorporation of 225Ac and sequester of daughter radionuclides: in vitro and in vivo studies. Journal of Controlled Release 2021;330:726-37. [DOI: 10.1016/j.jconrel.2021.01.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 6 |
Toro-gonzález M, Peacock A, Miskowiec A, Cullen DA, Copping R, Mirzadeh S, Davern SM. Tailoring the Radionuclide Encapsulation and Surface Chemistry of La(223Ra)VO4 Nanoparticles for Targeted Alpha Therapy. JNT 2021;2:33-50. [DOI: 10.3390/jnt2010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Alekseev I, Miroslavov A. Post-effects of radioactive decay in magnetite nano-crystals labelled with Auger- and internal conversion electron-emitters, alpha- and beta decay radionuclides. Radiation Physics and Chemistry 2020;177:109160. [DOI: 10.1016/j.radphyschem.2020.109160] [Reference Citation Analysis]
|
| 8 |
Kazakov AG, Garashchenko BL, Yakovlev RY, Vinokurov SE, Kalmykov SN, Myasoedov BF. Generator of Actinium-228 and a Study of the Sorption of Actinium by Carbon Nanomaterials. Radiochemistry 2020;62:592-8. [DOI: 10.1134/s1066362220050057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Toro-gonzález M, Dame AN, Mirzadeh S, Rojas JV. Encapsulation and retention of 225 Ac, 223 Ra, 227 Th, and decay daughters in zircon-type gadolinium vanadate nanoparticles. Radiochimica Acta 2020;108:967-77. [DOI: 10.1515/ract-2019-3206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Silindir-gunay M, Karpuz M, Ozer AY. Targeted Alpha Therapy and Nanocarrier Approach. Cancer Biotherapy and Radiopharmaceuticals 2020;35:446-58. [DOI: 10.1089/cbr.2019.3213] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 11 |
Majkowska-Pilip A, Gawęda W, Żelechowska-Matysiak K, Wawrowicz K, Bilewicz A. Nanoparticles in Targeted Alpha Therapy. Nanomaterials (Basel) 2020;10:E1366. [PMID: 32668687 DOI: 10.3390/nano10071366] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 12 |
Toro-González M, Dame AN, Foster CM, Millet LJ, Woodward JD, Rojas JV, Mirzadeh S, Davern SM. Quantitative encapsulation and retention of 227Th and decay daughters in core-shell lanthanum phosphate nanoparticles. Nanoscale 2020;12:9744-55. [PMID: 32324185 DOI: 10.1039/d0nr01172j] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 13 |
Washiyama K. Current Status of alpha emitters useful for targeted radionuclide therapy. Official Journal of the Japan Society of Drug Delivery System 2020;35:102-113. [DOI: 10.2745/dds.35.102] [Reference Citation Analysis]
|
| 14 |
Cędrowska E, Pruszyński M, Gawęda W, Żuk M, Krysiński P, Bruchertseifer F, Morgenstern A, Karageorgou MA, Bouziotis P, Bilewicz A. Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer. Molecules 2020;25:E1025. [PMID: 32106568 DOI: 10.3390/molecules25051025] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 15 |
Pérez-Medina C, Teunissen AJP, Kluza E, Mulder WJM, van der Meel R. Nuclear imaging approaches facilitating nanomedicine translation. Adv Drug Deliv Rev 2020;154-155:123-41. [PMID: 32721459 DOI: 10.1016/j.addr.2020.07.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 16 |
Roobol SJ, Hartjes TA, Slotman JA, de Kruijff RM, Torrelo G, Abraham TE, Bruchertseifer F, Morgenstern A, Kanaar R, van Gent DC, Houtsmuller AB, Denkova AG, van Royen ME, Essers J. Uptake and subcellular distribution of radiolabeled polymersomes for radiotherapy. Nanotheranostics 2020;4:14-25. [PMID: 31911891 DOI: 10.7150/ntno.37080] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 17 |
Loya J, Zhang C, Cox E, Achrol AS, Kesari S. Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy. CNS Oncol 2019;8:CNS40. [PMID: 31747784 DOI: 10.2217/cns-2019-0002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Alekseev I, Miroslavov A, Stepanova E. Post-effects of radioactive decay in ligands on biologically active transport platforms. Radiation Physics and Chemistry 2019;162:96-106. [DOI: 10.1016/j.radphyschem.2019.04.033] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Kruijff RM, Raavé R, Kip A, Molkenboer-Kuenen J, Morgenstern A, Bruchertseifer F, Heskamp S, Denkova AG. The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier. Sci Rep 2019;9:11671. [PMID: 31406320 DOI: 10.1038/s41598-019-48298-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 20 |
Toro-gonzález M, Dame AN, Mirzadeh S, Rojas JV. Gadolinium vanadate nanocrystals as carriers of α-emitters ( 225 Ac, 227 Th) and contrast agents. Journal of Applied Physics 2019;125:214901. [DOI: 10.1063/1.5096880] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 21 |
de Kruijff RM, Raavé R, Kip A, Molkenboer-Kuenen J, Roobol SJ, Essers J, Heskamp S, Denkova AG. Elucidating the Influence of Tumor Presence on the Polymersome Circulation Time in Mice. Pharmaceutics 2019;11:E241. [PMID: 31137479 DOI: 10.3390/pharmaceutics11050241] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 22 |
Garashchenko BL, Korsakova VA, Yakovlev RY. Radiopharmaceuticals Based on Alpha Emitters: Preparation, Properties, and Application. Phys Atom Nuclei 2018;81:1515-25. [DOI: 10.1134/s1063778818100071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 23 |
Dzhuzha D, Myasoyedov S. Radionuclide therapy with alpha-emitters. RDRT 2019. [DOI: 10.37336/2707-0700-2019-4-4] [Reference Citation Analysis]
|
| 24 |
Thiele NA, Wilson JJ. Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches. Cancer Biother Radiopharm 2018;33:336-48. [PMID: 29889562 DOI: 10.1089/cbr.2018.2494] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 25 |
Holzwarth U, Ojea Jimenez I, Calzolai L. A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy. EJNMMI Radiopharm Chem 2018;3:9. [PMID: 29888318 DOI: 10.1186/s41181-018-0042-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 26 |
Kozempel J, Mokhodoeva O, Vlk M. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators. Molecules 2018;23:E581. [PMID: 29510568 DOI: 10.3390/molecules23030581] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 27 |
Toro-gonzález M, Copping R, Mirzadeh S, Rojas JV. Multifunctional GdVO 4 :Eu core–shell nanoparticles containing 225 Ac for targeted alpha therapy and molecular imaging. J Mater Chem B 2018;6:7985-97. [DOI: 10.1039/c8tb02173b] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
